Latest Breaking News On - Mike cloonan - Page 1 : vimarsana.com

Phase 1 trial of SION-109 oral therapy doses first volunteer

Phase 1 trial of SION-109 oral therapy doses first volunteer
cysticfibrosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cysticfibrosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Mike cloonanDrug administrationSionna therapeutics

Sionna Therapeutics Announces Phase 1 Initiation for SION-109 in Cystic Fibrosis

/PRNewswire/ Sionna Therapeutics, a life sciences company dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF),.

United statesMike cloonanAdam daleyBerry company public relationsDrug administrationInvestigational new drugChief executive officerSionna therapeutics

NACFC 2023: Sionna s Series 2 molecules restore CFTR function

NACFC 2023: Sionna s Series 2 molecules restore CFTR function
cysticfibrosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cysticfibrosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

United statesGreg hurlbutMike cloonanSionna therapeuticCystic fibrosis newsAmerican cystic fibrosis conference

Sionna Therapeutics Presents Preclinical Data at 2023 North American Cystic Fibrosis Conference Demonstrating Series 2 NBD1 Stabilizers Normalize ΔF508-CFTR Function

/PRNewswire/ Sionna Therapeutics, a clinical-stage life sciences company dedicated to developing highly effective and differentiated treatments for cystic.

United statesAdam daleyGreg hurlbutMike cloonanBerry company public relationsDiscovery researchAmerican cystic fibrosis conferenceInvestigational new drugSenior vice presidentChief executive officerSionna therapeuticsHealth care amp hospitalsMedical pharmaceuticalsClinical trials amp medical discoveriesTrade show news

Sionna Therapeutics Announces Presentation of Preclinical Data on NBD1 Stabilizers at 46th European Cystic Fibrosis Conference

- Results from clinically predictive CFHBE model suggest NBD1 stabilizers enable multiple potential paths to full restoration of CFTR function -BO.

United statesMike cloonanAdam daleyGreg hurlbutBerry company public relationsEuropean cystic fibrosis societyDiscovery research of sionnaEuropean cystic fibrosis conferenceChief executive officerCombinations directly addressEnable fullSenior vice presidentDiscovery researchInvestigational new drug